In renal cell carcinoma, miR-429 was found to function as a tumor suppressor via regulation of E2F3, suggesting this potential development of miR-429-based prognostic and therapeutic approaches may be valuable for the treatment of renal cell carcinoma patients [69]. This evidence concerns the gene E2F3 and hereditary clear cell renal cell carcinoma.